Structured evidence table for Bacopa Reaction Time Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Bacopa Reaction Time Randomized Trial | Discussion This trial will provide evidence on BMFD's potential to preserve telomere length, support cognitive functions, and slow aging processes. | 2 | Pradeep HLNR (2026) | Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol. |
| Bacopa Reaction Time Randomized Trial | Findings are expected to inform preventive and personalized strategies, contributing to evidence-based applications of Bacopa monnieri in healthy aging. | 2 | Pradeep HLNR (2026) | Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol. |
| Bacopa Reaction Time Randomized Trial | Background Aging is an irreversible process shaped by genetic and environmental factors. | 2 | Pradeep HLNR (2026) | Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol. |
| Bacopa Reaction Time Randomized Trial | Programmed theories propose aging follows a biological clock, while error theories attribute it to environmental damage. | 2 | Pradeep HLNR (2026) | Effects of <i>Bacopa monnieri</i> herbal supplement on aging and neurocognitive functions, including neurophysiological assessments, in relation to constitution (<i>Prakriti</i>) in healthy adults: clinical trial protocol. |
| Bacopa Reaction Time Randomized Trial | New evidence shows that the gut–brain axis is a crucial modulator: intestinal dysbiosis and increased gut permeability may allow bacterial components (including lipopolysaccharide, LPS) and other metabolites to enter the circulation, triggering systemic inflammation and microglial activation in the brain. | 4 | Olajide Abosede Temitope (2026) | Phytochemical Profile, Antioxidant Activity, and Neuroprotective Effects of Bacopa monnieri Extract in a Lipopolysaccharide-Induced Dementia Model |
| Bacopa Reaction Time Randomized Trial | In addition, the oxygen radical antioxidant capacity (ORAC) assay revealed free radical scavenging capacity of 1.17 ± 0.01 µM TE/mg extract.C,D also shows the kinetic fluorescence decay curves of fluorescein and the net area under the curve (AUC), which also gives additional evidence on the antioxidant potential of the extract. | 4 | Olajide Abosede Temitope (2026) | Phytochemical Profile, Antioxidant Activity, and Neuroprotective Effects of Bacopa monnieri Extract in a Lipopolysaccharide-Induced Dementia Model |
| Bacopa Reaction Time Randomized Trial | In contrast, spontaneous alternation behavior, an indicator of working memory, was slightly reduced in the BME group (60.38 ± 6.05%) compared with the LPS (69.46 ± 8.53%), representing a 0.87% decrease, although this difference was not statistically significant (> 0.05;D). | 4 | Olajide Abosede Temitope (2026) | Phytochemical Profile, Antioxidant Activity, and Neuroprotective Effects of Bacopa monnieri Extract in a Lipopolysaccharide-Induced Dementia Model |
| Bacopa Reaction Time Randomized Trial | 1 2 3 4 Dementia is a neurodegenerative syndrome, a progressive condition characterized by memory loss as well as other cognitive impairments that significantly affect daily activities and quality of life []. | 4 | Olajide Abosede Temitope (2026) | Phytochemical Profile, Antioxidant Activity, and Neuroprotective Effects of Bacopa monnieri Extract in a Lipopolysaccharide-Induced Dementia Model |
Source documents